Tissue Engineering and Regenerative Medicine Therapies for Cell Senescence in Bone and Cartilage.
The bone repair and substitute have been developed for decades with the bone defect repair applied successfully in clinical. However, implant complications may occur in more challenging situations, bone cell senescence and osteoporosis. Due to certain microenvironment conditions, including hormonal, nutritional, and aging factors, the bone cell responses are regulated to alteration and end into cell senescence and osteoporosis. Thus, the bone tissue regeneration is limited with site morbidity increased, leading to bone grafts failure. In such pathological state, bone grafts and substitutes are companied with osteoporosis therapies to improve bone tissue engineering and to enhance bone graft healing. Those substitutes with osteoporosis therapeutic-based applications have been becoming a growing field of interest in bone repair. Bone grafts, such as scaffolds with anti-osteoporotic drugs releasing, surface therapeutic modified implants, are studied in aim to significantly increase low bone density as well as improve impaired bone regeneration. In this review, we discuss a throughout understanding in bone remodeling process, bone cell senescence and osteoporosis. Based on the understanding, the review concentrates on the treatments to the osteoporosis and the bone grafts applied in the bone senescence model and provide a future direction in clinical trial.